Abstract
The objective of this study was to evaluate the role of eNO changes post inhalative isocyanate challenge tests (ΔeNO) with regard to specific asthmatic reactions and unspecific bronchial hyperresponsiveness (BHR) to predict clinical and subclinical responses of isocyanate workers. Methods: 55 workers with isocyanate-related respiratory complaints (29 with BHR and 25 without BHR) underwent occupational-type challenge tests. We determined eNO before, during and up to 22 h after diagnostic isocyanate challenge. Results: The 12 asthmatic responders (22%) in the isocyanate-challenge test showed the highest eNO changes 22 h after challenge as well as a significant association between these changes and BHR. There was a positive association between an eNO increase of >50% and an asthmatic response when compared to nonresponders with an odds ratio of 6.1; 95% CI 1.4–26.3; P=0.02. More than half of the employees with BHR (52%) but only 20% of those without BHR developed an eNO rise of >50% after 22 h. Furthermore, a significant positive association was found between the combination of BHR plus eNO increase of 50% after 22 h and the maximum sRaw change (% of baseline value) during the period 0–22 h after isocyanate exposure. The combination of BHR and eNO increase of >50% was also associated with clinical symptoms during specific challenge tests (cough, shortness of breath, and/or rhinitis). Discussion and conclusions: An eNO increase 22 h post isocyanate challenge occurred in two-thirds of responders and in approximately half of nonresponders with BHR but only rarely in those without BHR. The combination of BHR and eNO increase in nonresponders may offer a new diagnostic tool to register subjects with an increased risk of developing occupational asthma. However, a large study group to perform follow-up investigations into this topic would be helpful to emphasize the importance of this finding.
Similar content being viewed by others
Abbreviations
- BHR:
-
Bronchial hyperresponsiveness
- eNO:
-
Exhaled nitric oxide
References
Allmers H, Chen Z, Barbinova L, Marczynski B, Baur X (2000) Challenge from methacholine, natural rubber latex, or 4,4(-diphenylmethane diisocyanate in workers with suspected sensitization affects exhaled nitric oxide (changes in exhaled NO levels after allergen challenges). Int Arch Occup Environ Health 73:181–186
Alvarez-Puebla MJ, Olaguibel-Rivera JM, Urbiolla-Marcilla E, Garcia BE, Tabar-Purroy AI (2001) Determinants of allergen-induced late asthmatic responses in mild asthmatics. Chest 119:120–127
Arshad SH (2005) Bronchial allergen challenge: a model for chronic allergic asthma? Clin Exp Allergy 30:12–15
Barbinova L, Baur X, Degens P, Huber H, Marczynski B, Czuppon AB (2000) Exposition gegenüber verschiedenen Isozyanaten und Asthmaentwicklung. Atemw-Lungenkrkh 26:364–366
Baur X, Huber H, Degens P, Allmers H, Ammon J (1998) Relation between occupational asthma case history, bronchial methacholine challenge, and specific test in patients with suspected occupational asthma. Am J Ind Med 33:114–122
Baur X, Marczynski B, Barbinova L, Degens P (2001) Arbeitplatzbezogene Expositionsteste mit dem Diisocyanat MDI. Atemw-Lungenkrkh 27:346–348
Baur X, Latza U, Barbinova L, Yu F (2003) Isocyanat–bedingte Gesundheitsgefahren. Arbeitsmed Sozialmed Umweltmed 38:270–277
Baur X, Barbinova L (2005) Latex allergen exposure increases exhaled nitric oxide in symptomatic health care workers. Eur Respir J 25:309–316
Bland JM, Altman DG (1986) Statistical methods for assessing agreement between two methods of clinical measurement. Lancet i:307–310
Cuzzocrea S, Mazzon E, Calabro G. (2000) Inducible nitric oxide synthase-knockout mice exhibit resistance to pleurisy and lung injury caused by carrageenan. Am J Respir Crit Care Med 162:1859–1866
Deschamps F, Prevost A, Lavaud F, Kochman S (1998) Mechanisms of occupational asthma induced by isocyanates. Ann Occup Hyg 42:33–36
Gratziou Ch, Lignos M, Dassiou M, Rooussos Ch. (1999) Influence of atopy on exhaled nitric oxide in patients with stable asthma and rhinitis. Eur Resp 14:897–901
Henriksen AH, Lingaas-Holmen T, Sue-Chu M, Bjermer L (2000). Combined use of exhaled nitric oxide and airway hyperresponsiveness in characterizing asthma cases in a large population survey. Eur Respir J 15:849–855
Ito K, Lim S, Caramori G, Chung KF, Barne PJ, Adcock IM (2001) Cigarette smoking reduces histone deacetylase 2 expresssion, enhances cytokine expression, and inhibits glucocortioid actions in alveolar macrophages. FASEB J 15:1110–1112
Jatakanon A, Lim S, Barnes PJ (2000). Changes in sputum eosinophils predict loss of asthma control. Am J Respir Crit Care Med 161:64–72
Kharitonov SA, O’Connor BJ, Evans DJ, Barnes PJ (1995) Allergen-induced late asthmatic reactions are associated with elevation of exhaled nitric oxide. Am J Respir Crit Care Med 153:454–457
Kharitonov SA, Robbins RA, Yates DH, Keating V, Barnes PJ (1995) Acute and chronic effects of cigarette smoking on exhaled nitric oxide. Am J Respir Crit Care Med 152:609–612
Kharitonov S, Alving K, Barnes PJ. (1997) Exhaled, nasal nitric oxide measurements: recommendations. The European Respiratory Society Task Force. Eur Respir J 10:1683–1693
Klein G, Matthys H (1986) Bronchiale Hyperreagibilität. Nachweis mit pharmakologischen Substanzen. Prax Klin Pneumol 40:156–166
Kuschner WG, D’Alessandro A, Wong H, Blanc PD (1996) Dose-dependent cigarette smoking-related inflammatory responses in healthy adults. Eur Respir J 9:1989–1994
Lee SK, Park HS, Lim HE, Kim SS, Nahm DH, LeeYM, Park CS (2003) Location of inducible nitric oxide synthase and endothelial constitutive nitric oxide synthase in airway mucosa of toluene diisocyanate-induced asthma. Allergy Asthma Proc 24:275–280
Lemière C, Romeo PA, Chaboillez S, Tremblay C, Malo JL (2002) Airway inflammation and functional changes after exposure to different concentrations of isocyanates. J Allergy Clin Immunol 110:641–646
Lund MB, Oksne PI Hamre R, Kongerud J. (2000) Increased nitric oxide in exhaled air: an early marker of asthma in non-smoking aluminium potroom workers? Occup Environ Med 57:274–278
McDonald JC, Keynes HL, Meredith SK (2000) Reported incidence of occupational asthma in the United Kingdom, 1989–1997. Occup Environ Med 57:823–829
Meredith SK, Bugler J, Clarke RL (2000) Isocyanate exposure and occupational asthma: a case-referent study. Occup Environ Med 57:830–836
Moody A, Fergusson W, Wells A, Bartley J, Kolbe J. (2000) Increased nitric oxide production in the respiratory tract in asymptomatic Pacific Islanders: an association with skin prick test reactivity to house dust mite. J Allergy Clin Immunol 105:895–899
Moscato G, Dellabianca A, Maestrelli P, Paggiaro P, Romano C, De Zotti R, Marabini A, Voltolini S, Crippa M, Previdi M, Brame B, Benzon R, Siracusa A (2002) Features and severity of occupational asthma upon diagnosis: an Italian multicentric case review. Allergy 57:236–242
Moscato G, Malo JL, Bernstein D (2003) Diagnosing occupational asthma: how, how much, how far? Eur Respir J 21:879–885
NFPA (ed) NFPA chemical hazard labels. http://www.delta.edu/slime/nfpakey.html
Obata H, Dittrick M, Chan H, Chan-Yeung M (1999) Sputum eosinophils and exhaled nitric oxide during late asthmatic reactions in patients with western red cedar asthma. Eur Respir J 13:489–495
Quanjer PH, Tammeling GJ, Cotes JE, Pedersen OF, Peslin R, Yernault JC (1993) Lung volumes and forced ventilatory flows. Eur Respir J 16(Suppl):5–40
Raulf-Heimsoth M, Baur X (1998) Pathomechanisms and pathophysiology of isocyanate-induced diseases–summary of present knowledge. Am J Ind Med 34:137–143
Raychaudhuri B, Dweik R, Connors MJ, Buhrow L, Malur A, Drazba J, Arroliga AC, Erzurum SC, Kavuni MS, Thomassen MJ (1999) Nitric oxide blocks nuclear factor-kB activation in alveolar macrophages. Am J Respir Cell Mol Biol 21:311–316
Robbins RA, Floreani AA, Von Essen SG, Sisson JH, Hill GE, Rubinstein I, Townley R (1996) Measurement of exhaled nitric oxide by three different techniques. Am J Respir Crit Care Med 153:1631–1635
Roquet A, Dahlen B, Kumlin M, Ihre E, Anstren G, Binks S, Dahlen SE. (1997) Combined antagonism of leukotrienes and histamine produces predominant inhibition of allergen-induced early and late phase airway obstruction in asthmatics. Am J Respir Crit Care Med 155:1856–1863
Rosenman KD, Reilly MJ, Kalinowski DJ (1997) A state-based surveillance system for work-related asthma. J Occup Environ Med 39:415–425
Saetta M, Turato G, Maestrelli P, Mapp CE, Fabbri LM (2001) Cellular and structural bases of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 163:1304–1309
Smith AD, Cowan JO, Filsell S, McLachlan Ch, Monti-Sheehan G, Jackson P, Taylor R (2003) Diagnosing asthma. Comparisons between exhaled nitric oxide measurement and conventional tests. Am J Respir Crit Care Med 199:473–478
Su Y, Han W, Giraldo C, De Li Y, Block ER (1998) Effect of cigarette smoke extract on nitric oxide synthase in pulmonary artery endothelial cells. Am J Respir Cell Mol Biol 19:819–825
Thomassen MJ, Raychaudhuri B, Dweik RA, Farver C, Buhrow L, Malur A, Connors MJ, Drazba J, Hammel J, Erzurum SC, Kavuru MS (1999) Nitric oxide regulation of asthmatic airway inflammation with segmental allergen challenge. J Allergy Clin Immunol 104:1174–1182
Wuethrich B, Schindler C, Medici TC, Zellweger JP, Leunberger P (1996) IgE levels, atopy markers and hay fever in relation to age, sex and smoking status in a normal adult Swiss population. Int Arch Allergy Immunol 111:396–402
Yamada K, Niimi A, Amitani R, Kawai M, Tanaka K, Kuze F (1993) Airway inflammatory cell dynamics during late asthmatic reactions induced by toluene diisocyanate in guinea pigs. II. Histological study. Arerugi 42(11):1692–1700
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Barbinova, L., Baur, X. Increase in exhaled nitric oxide (eNO) after work-related isocyanate exposure. Int Arch Occup Environ Health 79, 387–395 (2006). https://doi.org/10.1007/s00420-005-0051-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00420-005-0051-x